Halozyme Therapeutics, Inc.

Allspring Global Investments Holdings, LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/15/2026

Shares

29,938

Value ($000)

2,105

Weight

0.0%

2021 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/15/2026	2,105	0.0%	29,938	12/31/2025
2025 Q3	10/20/2025	2,107	0.0%	28,117	9/30/2025
2025 Q2	7/25/2025	428	0.0%	8,084	6/30/2025
2025 Q1	4/24/2025	2,532	0.0%	40,917	3/31/2025
2024 Q4	1/29/2025	2,234	0.0%	46,527	12/31/2024
2024 Q3	10/18/2024	34,533	0.1%	603,299	9/30/2024
2024 Q2	7/26/2024	35,754	0.1%	682,847	6/30/2024
2024 Q1	4/29/2024	28,318	0.0%	696,127	3/31/2024
2023 Q4	1/25/2024	26,907	0.0%	727,998	12/31/2023
2023 Q3	10/27/2023	33,894	0.1%	887,274	9/30/2023
2023 Q2	7/18/2023	11,661	0.0%	323,285	6/30/2023
2023 Q1	4/13/2023	9,269	0.0%	242,703	3/31/2023
2022 Q4	1/23/2023	22,658	0.0%	398,216	12/31/2022
2022 Q3	10/26/2022	29,405	0.1%	743,687	9/30/2022
2022 Q2	7/25/2022	27,545	0.0%	626,042	6/30/2022
2022 Q1	5/2/2022	27,872	0.0%	698,904	3/31/2022
2021 Q4	1/28/2022	35,784	0.0%	889,937	12/31/2021